CENTURY THERAPEUTICS INC (IPSC)

US15673T1007 - Common Stock

3.17  +0.14 (+4.62%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.23M5.20M0.000.000.00
Operating Expenses
127.42M129.03M94.88M49.18M20.03M
Research and Development
92.71M97.17M75.65M39.68M14.27M
Selling, General, and Administrative Expenses
34.71M31.86M19.24M9.50M5.77M
Operating Income
-125.18M-123.83M-94.88M-49.18M-20.03M
Interest Income/Expense
12.14M-1.43M-1.28M-380.00K0.00
Other Income/Expense
-383.00K4.42M380.00K700.00K1.21M
Non Recurring Items
-21.36M-10.00M0.00-4.72M-225.95M
Income Before Taxes
-134.79M-130.84M-95.78M-53.58M-244.77M
Income Tax
1.88M90.00K40.00KN/AN/A
Net Income
-136.67M-130.93M-95.82M-53.58M-244.77M
EBITDA
-112.14M-115.39M-91.13M-47.78M-19.78M
 
Per Share Data
EPS Diluted Total Ops
-2.30-2.27-2.96-7.16-32.91
Non GAAP EPS
-2.29-2.28N/AN/AN/A
 
Statistics
Profit Margin
-6115.12%-2517.88%N/AN/AN/A
Operating Profit Margin
-5600.94%-2381.35%N/AN/AN/A

All data in USD

Charts